Individuals and teams can make constant progress together with the company’s growth

As Boan Biotech continues to expand, our team and I have also made much progress. When we began screening, we found no antibodies at all, but we ended up with tens of thousands. We have to complete every process from the screening to assessment. We have also involved from monoclonal antibody, dual antibody to ADC and other fields. This is a long journey. It is an open, inclusive, pragmatic and international lab that keeps encouraging us to produce better products. Boan has developed a complete biopharmaceutical industry chain R&D model that covers antibody discovery, antibody assessment, nonclinical study, clinical study, drug registration and commercialization. With its diverse pipeline, Boan Biotech enjoys great potential for the future that will fully facilitate the on-going development of individuals and teams.

Boan Biotech sets the stage for employees to show their talents

Boan extremely values the development of innovative drugs, evidenced by its continuous investment and strong support for new drug R&D. It gives our scientists and technicians developing medicines a good platform to shine, to tap their talents and to create value. The company values the improvement of individual competence and capability. Boan Biotech ensures that all employees have access to the opportunities for skill improvement and career development, and can be passionate and motivated in their work. At the same time, the company takes such good care of us and inspires us, making us feel like we belong here.

New drug development requires patience

We develop new drugs to save patients, improve their survival rate and life quality. This really is a valuable and sacred task. Yet, it is also a challenging cause with much uncertainty and requires long-term investments. Drug development is a lonely journey, anyone choosing it as a career must be patient, persistent and tough enough to handle the pressure. We hope that more graduates will put what they have learned into practice and contribute their share to the innovation of China’s pharmaceutical industry.